Athem LLC

Morrisville, NC

UEI
F5X8LV38ETG7
CAGE
8GY38
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Manufacturer of Goods
  • Subcontinent Asian (Asian-Indian) American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2109 Jadewood Dr, Morrisville, NC 27560, USA
Website
athembio.com
Founded
2019
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Athem LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase II: a bioprocessing system to isolate and purify therapeutic antibodies directly from cell culture. -the… Grant · 2318892 National Science Foundation $999,998
Sbir phase i: medical device to isolate and purify therapeutic antibodies from recovered donors (covid-19) Grant · 2036188 Division of Industrial Innovation $255,943

Quick answers

What is Athem LLC's UEI?

Athem LLC's Unique Entity ID (UEI) in SAM.gov is F5X8LV38ETG7.

What is Athem LLC's CAGE code?

Athem LLC's CAGE code is 8GY38.

What is Athem LLC's primary NAICS code?

Athem LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Athem LLC located?

Athem LLC's physical address in SAM.gov is 2109 Jadewood Dr, Morrisville, NC 27560, USA.

Is Athem LLC registered in SAM.gov?

Yes. Athem LLC's SAM.gov registration is active through March 7, 2027.

What is Athem LLC's most recent federal award?

Athem LLC's most recent federal grant award is Sbir phase II: a bioprocessing system to isolate and purify therapeutic antibodies directly from cell culture. -the… (2318892), from National Science Foundation, on August 15, 2024.

On GovTribe

See Athem LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login